Navigation Links
ATHENA Clinical Results with Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress
Date:5/22/2008

al fibrillation or atrial flutter. Dronedarone is a multi-channel blocker that affects calcium, potassium and sodium channels and has anti-adrenergic properties. Dronedarone does not contain the iodine radical and did not show any evidence of thyroid or pulmonary toxicity in clinical trials.

Based upon this new clinical data, sanofi-aventis plans to submit a registration dossier to the European Medicines Agency (EMEA), and a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) during the 3rd quarter of 2008.

About sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Forward Looking Statements

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include product development, product potential projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future events, operations, products and services, and statements regarding future performance. Forward-looking statements are generally identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans" and similar expressions. Although sanofi-aventis' management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of whi
'/>"/>

SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress
2. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
3. Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration
4. Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference
5. Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
6. Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
7. Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
8. Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
9. Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System
10. Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting
11. Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientifics SpyGlass(R) Direct Visualization System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013 A decade-long JDRF-funded ... Helmholtz Zentrum München, Germany , is ... and the risk of developing type 1 diabetes (T1D), ... for the disease. The study, "Seroconversion to Multiple Islet ... was published today in The Journal of the ...
(Date:6/19/2013)... , June 19, 2013 The Physician-Patient Alliance for ... fatigue. The need to urgently address this issue ... Sentinel Event Alert #50 , "Medical device alarm safety in ... between January 2008 and June 2012, there were 98 alarm ... in death (82%) , 13 resulted in permanent loss ...
(Date:6/19/2013)... 2013  Caradigm today announced the availability ... to help healthcare organizations efficiently manage clinician ... their compliance with data privacy regulations. The ... in the delivery of advanced role lifecycle ... systems. (Photo: http://photos.prnewswire.com/prnh/20130619/SF34463LOGO ...
Breaking Medicine Technology:New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 2New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 3Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 2Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 3
... Oct. 20, 2011 Treating patients with the new ... in significantly higher per patient costs and higher net ... by pharmacy benefit manager Prime Therapeutics (Prime).The study will ... Pharmacy,s Educational Conference in Atlanta, Ga. Dabigatran ...
... today announced publication of a peer-reviewed paper that examines ... for removal of varicose veins in a clinical office ... Powered Phlebectomy in an Office Setting:  Procedural Considerations and ... M.D., FACS (AmeriVein Systems, Aurora, Illinois) and published in ...
Cached Medicine Technology:Study Finds New Blood Thinning Medication, Pradaxa®, Comes at High Cost 2InaVein, LLC Announces First Peer-reviewed Publication of TRIVEX® Used In-Office 2
(Date:6/19/2013)... Kansas City will host its first Ciclovia event on Sept. 7, ... of Main Street in the midtown area will be restricted to ... The Main Street Corridor Development and BikeWalkKC are ... the ranks of dozens of cities across the US and Americas ... and active lifestyles. , “Ciclovia is the perfect event for the ...
(Date:6/19/2013)... Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig,s ... be classified into four distinct stages, report pathologists with ... Pennsylvania in the Annals of Neurology . This ... shows, for the first time, how the fatal degenerative ... central nervous system to other regions of brain and ...
(Date:6/19/2013)... 2013 Ultimate Medical Academy (UMA) participated ... broadcast on WFLA News Channel 8. Since its inaugural ... $84 million for All Children's Hospital in St. Petersburg, ... Years of Miracles," marked the second year UMA volunteered ... worked the phones during the Telethon, which raised a ...
(Date:6/19/2013)... 2013 “We are proud to introduce the ... like it in the U.S.,” says Shaun Johnson, Retail & ... and inexpensive solution to a very expensive problem, considering customers ... fish,” he adds. , Each package of Pond Defender ... the shape of any water garden or pond. The discs ...
(Date:6/19/2013)... the mantra of neurologists treating stroke victims has been "time ... room quickly to receive a drug that dissolves the stroke-causing ... brain tissue is saved or lost. , But ... of giving the intravenous drug known as a tissue ... ischemic (clot-caused), stroke, the most common type of stroke. ...
Breaking Medicine News(10 mins):Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3Health News:Staging system in ALS shows potential tracks of disease progression, Penn study finds 2Health News:Ultimate Medical Academy Rallies in Support of All Children's Hospital 2Health News:Ultimate Medical Academy Rallies in Support of All Children's Hospital 3Health News:Timely treatment after stroke is crucial, UCLA researchers report 2Health News:Timely treatment after stroke is crucial, UCLA researchers report 3
... with early rheumatoid arthritis (RA) who are current smokers were ... tumor necrosis factor (TNF) inhibitors than those who never smoked. ... patients who smoked in the past did not experience a ... appear in the January 2011 issue of Arthritis & ...
... is potentially more potent, longer lasting and less ... study led by a Loyola University Health System ... a similar chemical structure to standard morphine. Dr. ... study they performed in rats "demonstrated potential clinical ...
... glaucoma tests requiring a visit to the ophthalmologist could ... by an engineer at the University of Arizona. ... sensors, specially designed microchips, and math-based programmed procedures has ... Engineering. The easy-to-use probe gently rubs the eyelid and ...
... from Virginia Mason Medical Center in Seattle, WA, have ... inappropriate medical imaging, including unnecessary computed tomography (CT) and ... in the January issue of the Journal of ... "Clinical decision support systems are point-of-order decision ...
... clinicians frequently use portable media (CDs, DVDs) to review ... magnetic resonance imaging (MRI) and computed tomography (CT) scans, ... portable media exist, according to a study in the ... College of Radiology ( www.jacr.org ). "Because ...
... DATA SHOWS OMALIZUMAB SAFE AND EFFECTIVE FOR MODERATE TO SEVERE ... New research suggests that subcutaneous omalizumab is safe and effective ... in children and adults. Researchers from Uruguay, Argentina, and Chile ... omalizumab and 1,546 received a placebo. At the end of ...
Cached Medicine News:Health News:Current smokers with early rheumatoid arthritis less responsive to TNF inhibitors, methotrexate 2Health News:Experimental drug more potent, longer lasting than morphine 2Health News:New glaucoma test allows earlier, more accurate detection 2Health News:Study finds problems with reviewing medical images from portable media 2Health News:News briefs from the January issue of Chest 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: